As a practising pediatrician, what I can offer to the committee is that it's important that we have the complex and complicated conversation about how we're going to regulate nicotine more broadly and how we're going to maintain and preserve access to nicotine replacement therapy for those individuals who need it, while simultaneously restricting access to new and novel threats. I think that is a broader conversation that's important for the public to have.
On November 7th, 2024. See this statement in context.